Indoco Remedies Limited - Company Profile

Q: Who are the current directors of Indoco Remedies Limited?

The current directors of Indoco Remedies Limited are Vasudha Vasant Kamat, Anand Madhusudan Nadkarni, Ajay Prasan Mulgaokar, Pramod Ramchandra Ghorpade, Satish Madhav Shenoy, Abhijit Yashawant Gore, Sundeep Vasant Bambolkar, Aditi Milind Panandikar, Suresh Govind Kare, Hariharan Ramanathan, Ramanathan Hariharan.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1947.

1947 Mumbai, Maharashtra, India Active

Last Updated: December 30, 2025

Access Report

About Indoco Remedies Limited

Indoco Remedies Limited, a active public limited company, was established on 23 August 1947 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L85190MH1947PLC005913. Registered under ROC Roc Mumbai. it is listed on BSE: 532612 and NSE: INDOCO. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹18.45 Cr.

It upholds a compliant status. In 2024, it reported revenue of ₹1,799.32 Cr and a net worth of ₹1,126.62 Cr. Employing 6,460 professional, Its leadership includes Vasudha Vasant Kamat (Director), Anand Madhusudan Nadkarni (Director), Ajay Prasan Mulgaokar (Director). Past directors included Divakar Madhusudan Gavaskar, Sunil Dattatraya Joshi, Anil Bhalchandra Kale. It holds ₹684.06 Cr open charges and ₹717.82 Cr settled loans. Its latest AGM occurred on 11 September 2025, with the balance sheet filed on 31 March 2025. It is based at Indoco House 166 Cst Roadvidyanagari Marg Kalina Santacruz East, Mumbai, Maharashtra, 400098.

Company Details

CIN/LLPIN
L85190MH1947PLC005913
Registration Number
005913
Incorporation Date
23 August 1947
Authorized Capital
₹25.00 Cr
Paid-Up Capital
₹18.45 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 532612, NSE: INDOCO)
Company Status
Active

Key Metrics

Authorised Capital ₹ 25.00 Cr as on 30-12-2025
Paid Up Capital ₹ 18.45 Cr as on 30-12-2025
Company Age 78 Year, 5 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 684.06 Cr as on 30-12-2025
Satisfied Charges ₹ 717.82 Cr as on 30-12-2025
Revenue Growth **** 7.81% (FY 2024)
Profit Growth **** -17.49% (FY 2024)
Ebitda **** -9.44% (FY 2024)
Net Worth 9.70% (FY 2024)
Total Assets **** 18.13% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Indoco Remedies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Indoco Remedies Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vasudha Vasant Kamat	Director	27 Mar 2020	Current
Anand Madhusudan Nadkarni	Director	28 May 2014	Current
Ajay Prasan Mulgaokar	Director	01 Apr 2024	Current
Pramod Ramchandra Ghorpade	Cfo	02 Nov 2021	Current
Satish Madhav Shenoy	Director	01 Apr 2024	Current
Abhijit Yashawant Gore	Director	03 Oct 2020	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	31 Mar 2024	Past
Pramod Abcsdd	Company Secretary	31 Aug 2017	Past
Pramod Abcsdd	Company Secretary	09 May 2007	Past
Pramod Abcsdd	Additional Director	24 Sep 2020	Past
Pramod Abcsdd	Additional Director	22 Dec 2007	Past
Pramod Abcsdd	Director	09 Dec 2011	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Indoco Remedies.

Indoco Remedies Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7.81% increase. The company also saw a substantial fall in profitability, with a 17.49% decrease in profit. The company's net worth moved up by a moderate rise of 9.7%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

7.81%

*******

Revenue from Operations

*******

7.45%

*******

Total Assets

*******

18.13%

*******

Profit or Loss

*******

-17.49%

*******

Net Worth

*******

9.70%

*******

EBITDA

*******

-9.44%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Indoco Remedies?

In 2024, Indoco Remedies had a promoter holding of 58.72% and a public holding of 41.28%. The company had 2 Subsidiaries and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹6,840,565,000.00

Satisfied Charges

₹7,178,209,176.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 459.00 Cr
Others : 170.00 Cr
Idbi Bank Limited : 14.00 Cr
State Bank Of India : 13.65 Cr
Standard Chartered Bank : 10.00 Cr
Others : 17.41 Cr

Latest Charge Details

Date	Lender	Amount	Status
20 Apr 2025	Hdfc Bank Limited	₹244.00 Cr	Open
27 Feb 2025	Others	₹50.00 Cr	Open
27 Jun 2024	Hdfc Bank Limited	₹42.00 Cr	Open
30 May 2024	Hdfc Bank Limited	₹28.00 Cr	Open
14 Dec 2023	Hdfc Bank Limited	₹50.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Indoco Remedies?

Indoco Remedies has a workforce of 6460 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Indoco Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indoco Remedies's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Indoco Remedies

Recent Activity within the Organization

Annual General Meeting

Indoco Remedies Limited last Annual general meeting of members was held on 11 Sep 2025 as per latest MCA records. was recorded as a recent event.
11 Sep 2025
Charges

Progress on A charge with Hdfc Bank Limited amounted to Rs. 244.00 Cr with Charge ID 101090244 was registered on 20 Apr 2025. was documented.
20 Apr 2025
Balance Sheet

Progress on Indoco Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
31 Mar 2025
Charges

A charge with Others amounted to Rs. 50.00 Cr with Charge ID 101059602 was registered on 27 Feb 2025. was recorded as a recent event.
27 Feb 2025
Charges

The activity A charge registered on 14 Dec 2017 via Charge ID 100141258 with Others was fully satisfied on 17 Feb 2025. was completed.
17 Feb 2025
Charges

The activity A charge registered on 20 Aug 2021 via Charge ID 100478315 with Others was fully satisfied on 12 Jul 2024. was completed.
12 Jul 2024

Explore recent activity and updates - View Recent Activity